NCT00796068 2023-02-17Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood TransplantFred Hutchinson Cancer CenterPhase 2 Completed130 enrolled 21 charts
NCT00822393 2020-07-30Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)medac GmbHPhase 3 Completed570 enrolled 1 FDA
NCT02333058 2020-05-04Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignanciesmedac GmbHPhase 2 Completed70 enrolled
NCT00491634 2015-12-02Treosulfan-based Conditioning for Transplantation in AML/MDSSheba Medical CenterPhase 2 Completed24 enrolled
NCT00253513 2012-06-01Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeOHSU Knight Cancer InstitutePhase 1/2 Completed60 enrolled 15 charts
NCT01062490 2010-02-04Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)medac GmbHPhase 2 Completed45 enrolled